EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Genomic and in Silico Analysis Reveals Mitochondrially Encoded Cytochrome C Oxidase III (MT—CO3) Overexpression and Potential Neem-Derived Inhibitors in Breast Cancer

Oluwaseun E Agboola iD, Samuel S Agboola, Oluwatoyin M Oyinloye, Abimbola E Fadugba, Esther Y Omolayo, Zainab A Ayinla, Foluso O Osunsanmi iD, Oluranti E Olaiya, Folake O Olojo, Basiru O Ajiboye, Babatunji E Oyinloye iD

Genes · 30.04.2025 · 16 (5) · 546

DOI: 10.3390/genes16050546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 30.04.2025. Verfasst von Oluwaseun E Agboola und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Drug Research and Development, Bogoro Research Centre, Afe Babalola University, Ado-Ekiti 360001, Nigeria. Hauptthemen laut MEDLINE: Breast Neoplasms, Electron Transport Complex IV, Electron Transport Complex III. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The increasing global incidence of breast cancer calls for the identification of new therapeutic targets and the assessment of possible neem-derived inhibitors by means of computational modeling and integrated genomic research.

Methods

Originally looking at 59,424 genes throughout 42 samples, we investigated gene expression data from The Cancer Genome Atlas—Breast Cancer (TCGA-BRCA) dataset. We chose 286 genes for thorough investigation following strict screening for consistent expression. R’s limma package was used in differential expression analysis. The leading candidate’s protein modeling was done with Swiss-ADME and Discovery Studio. Molecular docking studies, including 132 neem compounds, were conducted utilizing AutoDock Vina.

Results

Among the 286 examined, mitochondrially encoded cytochrome C oxidase III (MT—CO3) turned out to be the most greatly overexpressed gene, showing consistent elevation across all breast cancer samples. Protein modeling revealed a substantial hydrophobic pocket (volume: 627.3 Å3) inside the structure of MT—CO3. Docking investigations showed five interesting neem-derived inhibitors: 7-benzoylnimbocinol, nimolicinol, melianodiol, isonimocinolide, and stigmasterol. Strong binding affinities ranging from −9.2 to −11.5 kcal/mol and diverse interactions with MT—CO3, mostly involving the residues Phe214, Arg221, and Trp58, these molecules displayed. With hydrophobic interactions dominant across all chemicals, fragment contribution analysis revealed that scaffold percentage greatly influences binding effectiveness. Stigmasterol revealed greater drug-likeness (QED = 0.79) despite minimal interaction variety, while 7-benzoylnimbocinol presented the best-balanced physicochemical profile.

Conclusion

Connecting traditional medicine with current genomics and computational biology, this work proposes a methodology for structure-guided drug design and development using neem-derived chemicals and finds MT—CO3 as a potential therapeutic target for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsElectron Transport Complex IVElectron Transport Complex IIIHumansFemaleMolecular Docking SimulationGene Expression Regulation, NeoplasticGenomicsComputer SimulationMitochondria

Stichwörter der Autor:innen

MT—CO3breast cancermitochondrial therapeuticsmolecular dockingneem compounds

Substanzen

Electron Transport Complex IVElectron Transport Complex III

Autor:innen und Institutionen

  • Institute for Drug Research and Development, Bogoro Research Centre, Afe Babalola University, Ado-Ekiti 360001, Nigeria.
  • Damsem Scientific Laboratory and Research, Ado-Ekiti 360102, Nigeria.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Afe Babalola University, Ado-Ekiti 360001, Nigeria.
  • Department of Biological Sciences, College of Sciences, Afe Babalola University, P.M.B 5454, Ado-Ekiti 360001, Nigeria.
  • Department of Biology, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
  • Biotechnology and Structural Biology (BSB) Group, Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa.

ORCID-Profile: Oluwaseun E Agboola, Foluso O Osunsanmi, Babatunji E Oyinloye

Zitieren

APA

Agboola, O. E., Agboola, S. S., Oyinloye, O. M., Fadugba, A. E., Omolayo, E. Y., Ayinla, Z. A., Osunsanmi, F. O., Olaiya, O. E., Olojo, F. O., Ajiboye, B. O., & Oyinloye, B. E. (2025). Integrative Genomic and in Silico Analysis Reveals Mitochondrially Encoded Cytochrome C Oxidase III (MT—CO3) Overexpression and Potential Neem-Derived Inhibitors in Breast Cancer. Genes, 16(5), 546. https://doi.org/10.3390/genes16050546

Vancouver

Agboola OE, Agboola SS, Oyinloye OM, Fadugba AE, Omolayo EY, Ayinla ZA, et al. Integrative Genomic and in Silico Analysis Reveals Mitochondrially Encoded Cytochrome C Oxidase III (MT—CO3) Overexpression and Potential Neem-Derived Inhibitors in Breast Cancer. Genes. 2025;16(5):546. doi:10.3390/genes16050546

BibTeX
@article{Agboola2025,
  author = {Agboola, Oluwaseun E and Agboola, Samuel S and Oyinloye, Oluwatoyin M and Fadugba, Abimbola E and Omolayo, Esther Y and Ayinla, Zainab A and Osunsanmi, Foluso O and Olaiya, Oluranti E and Olojo, Folake O and Ajiboye, Basiru O and Oyinloye, Babatunji E},
  title = {Integrative Genomic and in Silico Analysis Reveals Mitochondrially Encoded Cytochrome C Oxidase III (MT—CO3) Overexpression and Potential Neem-Derived Inhibitors in Breast Cancer},
  journal = {Genes},
  year = {2025},
  volume = {16},
  number = {5},
  pages = {546},
  doi = {10.3390/genes16050546}
}
Kostenlos starten →